Developing treatments for cognitive deficits in schizophrenia: the challenge of translation.
about
Translational Rodent Paradigms to Investigate Neuromechanisms Underlying Behaviors Relevant to Amotivation and Altered Reward Processing in SchizophreniaInvestigating the mechanism(s) underlying switching between states in bipolar disorderAnimal models of gene-environment interaction in schizophrenia: A dimensional perspective.Behavioral, Neurophysiological, and Synaptic Impairment in a Transgenic Neuregulin1 (NRG1-IV) Murine Schizophrenia Model.GlyT-1 Inhibition Attenuates Attentional But Not Learning or Motivational Deficits of the Sp4 Hypomorphic Mouse Model Relevant to Psychiatric DisordersThe effect of COMT Val158Met and DRD2 C957T polymorphisms on executive function and the impact of early life stress.Potential of Oxytocin in the Treatment of SchizophreniaKetamine and phencyclidine: the good, the bad and the unexpected.Differences in the performance of NK1R-/- ('knockout') and wildtype mice in the 5‑Choice Continuous Performance Test.Wet or dry: translatable "water mazes" for mice and humansChemogenetic Inactivation of Dorsal Anterior Cingulate Cortex Neurons Disrupts Attentional Behavior in Mouse.Dopamine D1 receptor activation improves PCP-induced performance disruption in the 5C-CPT by reducing inappropriate responding.Modeling neurodevelopmental cognitive deficits in tasks with cross-species translational validityPerspectives on the Use of eHealth in the Management of Patients With Schizophrenia.Preclinical profile of ITI-214, an inhibitor of phosphodiesterase 1, for enhancement of memory performance in rats.Physical Exercise Alleviates Health Defects, Symptoms, and Biomarkers in Schizophrenia Spectrum Disorder.A Review of Oxytocin's Effects on the Positive, Negative, and Cognitive Domains of Schizophrenia.Ceramide and Its Related Neurochemical Networks as Targets for Some Brain Disorder Therapies.Oxytocin effects in schizophrenia: Reconciling mixed findings and moving forward.Drugs, games, and devices for enhancing cognition: implications for work and society.The Five-Choice Continuous Performance Task (5C-CPT): A Cross-Species Relevant Paradigm for Assessment of Vigilance and Response Inhibition in Rodents.Cognitive functioning and employment among people with schizophrenia in vocational rehabilitation.Effects of haloperidol, olanzapine, ziprasidone, and PHA-543613 on spatial learning and memory in the Morris water maze test in naïve and MK-801-treated mice.An mGlu5-Positive Allosteric Modulator Rescues the Neuroplasticity Deficits in a Genetic Model of NMDA Receptor Hypofunction in Schizophrenia.Relationship between effortful motivation and neurocognition in schizophrenia.The 5 choice continuous performance test (5C-CPT): A novel tool to assess cognitive control across species.Cross-Species Neurophysiological Biomarkers of Attentional Dysfunction in Schizophrenia: Bridging the Translational Gap.Neurophysiological Characterization of Attentional Performance Dysfunction in Schizophrenia Patients in a Reverse-Translated Task.Effects of 2-bromoterguride, a dopamine D2 receptor partial agonist, on cognitive dysfunction and social aversion in rats.Improvement of attention with amphetamine in low- and high-performing rats.Associations of NEUROD2 polymorphisms and change of cognitive dysfunctions in schizophrenia and schizoaffective disorder after eight weeks of antipsychotic treatment.Validation of the human odor span task: effects of nicotine.Reverse translated and gold standard continuous performance tests predict global cognitive performance in schizophrenia.Metabotropic Glutamate Receptor 5 as a Target for the Treatment of Depression and Smoking: Robust Preclinical Data but Inconclusive Clinical Efficacy.The Effects of Cariprazine and Aripiprazole on PCP-Induced Deficits on Attention Assessed in the 5-Choice Serial Reaction Time Task.
P2860
Q26801568-2C12548E-AF96-4B1D-94A0-08838ABF0643Q28084519-20E71158-4278-4238-8E59-01F7066C792BQ30367009-68F115EC-125A-4C3A-BD1E-80B999C9F5DAQ30371601-9F171DD7-1AEF-4529-9939-173C3D082DC5Q30756194-17944C05-3A60-403B-8F89-3ACBF74E06C8Q33695382-989B05C8-53F2-4907-A8B8-3165B0D64FF8Q33761384-BCF9E431-E826-4C1F-80DF-A2437FC0D945Q34480719-EAC5FA27-D2A8-4A6A-ACC0-AFF304EC58B0Q36381454-B4C80DF4-AEFA-451B-A83F-FC81235635B5Q36515128-DC826667-930B-44B9-87FF-C3F0706658C0Q36565626-71408ECB-6802-455F-8D8A-784B64FF8572Q36618769-18750D58-A531-4FC6-A0C1-AD7F4044667EQ37126507-CDB559A4-B1B5-4EDC-A6B0-C3862A8FAD85Q37149822-56329DA3-0805-42DF-9860-E026B2620FE7Q37166063-78C49D3C-A605-4AB4-B6FB-85F34191925BQ38547002-7E226B1D-9F5A-4675-9AC8-4F97E235EB25Q38593718-7F30E70C-32E1-4DA4-9A07-8BFEA32D1F48Q38607507-FC6DCFA9-FE12-4523-9712-2E42AD2769C8Q38683538-B9DB292F-4754-4E55-83F5-34862D80D75EQ38797653-5A856A79-EC1E-4FEA-9804-C4A97F6D5462Q39042678-AACB51E5-57A8-4E00-95DA-7B9F848D5EFCQ39674981-D3ED5362-9493-4E6D-BD10-1FAA27AF4C59Q41449158-F26B78DF-6713-4C00-858E-C472AD78E5D2Q42710424-F9FFDAA6-BBFA-405B-BD4C-E71A50830EB6Q43892897-DFD3C6EA-17BB-4D84-9390-A49459E90209Q46014866-7B44A802-78C5-4113-B4F9-7E9CFF05AB2BQ46250546-C0617F1E-7531-42E8-8DC3-DD42070978DEQ46447322-C0AD603F-E8EA-468A-8AF8-3513F18B048AQ47669147-97410A94-708F-45DA-8020-9EA04AE1C9DFQ47971648-B7AB23B9-DDB2-4A54-9944-A68C8D0606F5Q50439837-01A97483-2A4C-4108-8666-834F0C1B57CBQ50574690-D42E617C-92D1-4F36-8381-168D4912ACD4Q52593163-00DFA740-1870-4F65-9048-638658B48718Q52600080-31AEC819-05EA-462A-806D-37FD9320FC03Q52688732-79B9F607-C6F7-4474-B571-701B62ADE186
P2860
Developing treatments for cognitive deficits in schizophrenia: the challenge of translation.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Developing treatments for cogn ...... the challenge of translation.
@ast
Developing treatments for cogn ...... the challenge of translation.
@en
type
label
Developing treatments for cogn ...... the challenge of translation.
@ast
Developing treatments for cogn ...... the challenge of translation.
@en
prefLabel
Developing treatments for cogn ...... the challenge of translation.
@ast
Developing treatments for cogn ...... the challenge of translation.
@en
P2860
P356
P1476
Developing treatments for cogn ...... the challenge of translation.
@en
P2093
P2860
P304
P356
10.1177/0269881114555252
P407
P577
2014-12-16T00:00:00Z